{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:24Z","timestamp":1792643844844,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T00:00:00Z","timestamp":1296604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00415-011-5913-4","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T17:45:52Z","timestamp":1296582352000},"page":"1240-1246","source":"Crossref","is-referenced-by-count":16,"title":["Psychosocial aspects in myasthenic patients treated by plasmapheresis"],"prefix":"10.1007","volume":"258","author":[{"given":"Yu-Tai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmay","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou-Chang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiann-Horng","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,2]]},"reference":[{"key":"5913_CR1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB (2008) Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 38:957\u2013963","journal-title":"Muscle Nerve"},{"key":"5913_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000658-199608000-00017","volume":"2","author":"C Busch","year":"1996","unstructured":"Busch C, Machens A, Pichlmeier U (1996) Long-term outcomes and quality of life after thymectomy for myasthenia gravis. Ann Surg 2:225\u2013232","journal-title":"Ann Surg"},{"key":"5913_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcn152","volume":"102","author":"A Chaudhuri","year":"2009","unstructured":"Chaudhuri A, Behan PO (2009) Myasthenic crisis. QJ Med 102:97\u2013107","journal-title":"QJ Med"},{"key":"5913_CR4","first-page":"43","volume":"50","author":"YT Chen","year":"2003","unstructured":"Chen YT, Tsay SL, Lin PF (2003) The relationships between illness perception, mood and quality of life in myasthenia gravis patients. J Nurs 50:43\u201350 (in Chinese)","journal-title":"J Nurs"},{"key":"5913_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archneur.1993.00540060055018","volume":"50","author":"S Doering","year":"1993","unstructured":"Doering S, Henze T, Sch\u00fcssler G (1993) Coping with myasthenia gravis and implications for psychotherapy. Arch Neurol 50:617\u2013620","journal-title":"Arch Neurol"},{"key":"5913_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.autrev.2007.01.001","volume":"6","author":"M Garc\u00eda-Carrasco","year":"2007","unstructured":"Garc\u00eda-Carrasco M, Esc\u00e1rcega RO, Fuentes-Alexandro S, Riebeling C, Cervera R (2007) Therapeutic options in autoimmune myasthenia gravis. Autoimmun Rev 6:373\u2013378","journal-title":"Autoimmun Rev"},{"key":"5913_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.1996.tb00512.x","volume":"93","author":"A J\u00f8nsson","year":"1996","unstructured":"J\u00f8nsson A, Dock J, Ravnborg MH (1996) Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 93:229\u2013235","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 2","key":"5913_CR8","doi-asserted-by":"crossref","first-page":"II107","DOI":"10.1007\/s00415-007-2026-1","volume":"254","author":"T Klauer","year":"2007","unstructured":"Klauer T, Schneider W, Zettl UK (2007) Coping with neuroimmunological diseases. J Neurol 254(Suppl 2):II107\u2013II111","journal-title":"J Neurol"},{"key":"5913_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00900502","volume":"243","author":"GJ Lankhorst","year":"1996","unstructured":"Lankhorst GJ, Jelles F, Smits RC, Polman CH, Kuik DJ, Pfennings LE, Cohen L, van der Ploeg HM, Ketelaer P, Vleugels L (1996) Quality of life in multiple sclerosis: the disability and impact profile. J Neurol 243:469\u2013674","journal-title":"J Neurol"},{"key":"5913_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.cnd.0000138445.13978.e4","volume":"6","author":"J Lundeen","year":"2004","unstructured":"Lundeen J, Fisher J, Kothari MJ (2004) Frequency of anxiety in myasthenia gravis. J Clin Neuromuscul Dis 6:9\u201312","journal-title":"J Clin Neuromuscul Dis"},{"key":"5913_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000297753","volume":"34","author":"AH Maniaol","year":"2010","unstructured":"Maniaol AH, Brunborg C, Tallaksen CME (2010) Development and validation of a self-administered questionnaire for myasthenia gravis patients. Neuroepidemiology 34:253\u2013261","journal-title":"Neuroepidemiology"},{"key":"5913_CR12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jnnp.65.4.460","volume":"65","author":"N Murphy","year":"1998","unstructured":"Murphy N, Confavreux C, Haas J, Konig N, Roullet E, Sailer M, Young C, Merot JL (1998) Quality of life in multiple sclerosis in France, Germany, and United Kingdom. J Neurol Neurosurg Psychiatry 65:460\u2013466","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5913_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, Tonali P (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363\u2013369","journal-title":"Neurol Sci"},{"key":"5913_CR14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/1097-4598(200009)23:9<1402::AID-MUS11>3.0.CO;2-B","volume":"23","author":"RH Paul","year":"2000","unstructured":"Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23:1402\u20131406","journal-title":"Muscle Nerve"},{"key":"5913_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.neuropsych.12.4.499","volume":"12","author":"RH Paul","year":"2000","unstructured":"Paul RH, Cohen RD, Goldstein JM, Gilchrist JM (2000) Severity of mood, self-evaluation, and vegetative symptoms of depression in myasthenia gravis. Neuropsychiatry Clin Neurosci 12:499\u2013501","journal-title":"Neuropsychiatry Clin Neurosci"},{"key":"5913_CR16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.1034","volume":"24","author":"RH Paul","year":"2001","unstructured":"Paul RH, Nash JM, Cohen RA, Gilchrist JM, Goldstein JM (2001) Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 24:512\u2013515","journal-title":"Muscle Nerve"},{"key":"5913_CR17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.47.5.1233","volume":"47","author":"LH Phillip II","year":"1996","unstructured":"Phillip LH II, Torner JC (1996) Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 47:1233\u20131238","journal-title":"Neurology"},{"key":"5913_CR18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","volume":"II","author":"AJ Pinching","year":"1976","unstructured":"Pinching AJ, Peters DK, Newsom-Davis J (1976) Remission of myasthenia gravis following plasma-exchange. Lancet II:1373\u20131376","journal-title":"Lancet"},{"key":"5913_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","volume":"71","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Hart IK, Mantegazza R et al (2008) An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 71:400\u2013406","journal-title":"Neurology"},{"key":"5913_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-008-0001-y","volume":"30","author":"EJ Sitek","year":"2009","unstructured":"Sitek EJ, Bili\u0144ska MM, Wieczorek D, Nyka WM (2009) Neuropsychological assessment in myasthenia gravis. Neurol Sci 30:9\u201314","journal-title":"Neurol Sci"},{"key":"5913_CR21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","volume":"48","author":"CE Thomas","year":"1997","unstructured":"Thomas CE, Mayer SA, Gungor Y et al (1997) Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 48:1253\u20131260","journal-title":"Neurology"},{"key":"5913_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/hs0202.102335","volume":"33","author":"IC Schaaf Van der","year":"2002","unstructured":"Van der Schaaf IC, Brilstra EH, Rinkel GJE, Bossuyt PM, van Gijn J (2002) Quality of life, anxiety, and depression in patients with an intracranial aneurysm or arterio-venous malformation. Stroke 33:440\u2013443","journal-title":"Stroke"},{"key":"5913_CR23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00005650-199606000-00004","volume":"34","author":"FD Wolinsky","year":"1996","unstructured":"Wolinsky FD, Stump TE (1996) A measurement model of the Medical Outcomes Study 36-Item Short-Form Health Survey in a clinical sample of disadvantaged, older, black, and white men and women. Med Care 34:537\u2013548","journal-title":"Med Care"},{"key":"5913_CR24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1600-0404.2001.104002078.x","volume":"104","author":"JH Yeh","year":"2001","unstructured":"Yeh JH, Chen WH, Chiu HC (2001) Double filtration plasmapheresis in the treatment of myasthenic crisis\u2013analysis of prognostic factors and efficacy. Acta Neurol Scand 104:78\u201382","journal-title":"Acta Neurol Scand"},{"key":"5913_CR25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0404.1999.tb00401.x","volume":"100","author":"JH Yeh","year":"1999","unstructured":"Yeh JH, Chiu HC (1999) Double filtration plasmapheresis in myasthenia gravis-analysis of clinical efficacy and prognostic parameters. Acta Neurol Scand 100:305\u2013309","journal-title":"Acta Neurol Scand"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5913-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-5913-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5913-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:13:05Z","timestamp":1559070785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5913-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,2]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["5913"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5913-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,2]]}}}